Blog
cAMP Functional Assays: How Researchers Measure Whether a Peptide Actually Activates a Receptor
Binding tells you that a peptide touches a receptor. It does not tell you whether the receptor switches on. For many peptide receptors, the simplest way to see activation is to measure a small molecule inside the cell called cyclic AMP, or cAMP.
Key takeaways
- Receptors coupled to Gs raise cAMP, and those coupled to Gi lower it.
- HTRF assays are competitive: more cAMP in the sample means less signal.
- GloSensor assays use a light-producing protein so cAMP can be followed live.
- A phosphodiesterase inhibitor is usually added to stop cAMP from being broken down.
- EC50 values depend on cell line, receptor level and incubation time, so always run a reference agonist.
Why cAMP
Many peptide hormones act on G protein-coupled receptors. When a receptor coupled to the Gs protein is activated, it stimulates an enzyme called adenylyl cyclase, which turns ATP into cAMP. When the receptor couples to Gi, the opposite happens. Receptors for glucagon, GLP-1, GIP and the melanocortins all use this pathway, so measuring cAMP is a natural way to compare compounds. See how cAMP itself was discovered and the melanocortin receptor family.
Two common formats
In HTRF, cells are treated with the peptide, then lysed with reagents containing a labeled cAMP and a labeled antibody. Cellular cAMP competes with the labeled cAMP, so more cAMP in the cells means less energy transfer and a lower signal. The result is read on a plate reader and compared with a standard curve.
In GloSensor and similar assays, the cells carry a biosensor that glows more when cAMP rises. You add the substrate, add the peptide, and watch the light in real time. That gives kinetics as well as endpoints, which helps in studying desensitization.
Setting up the experiment
- Pick a cell line with a known, stable level of the receptor, and keep passage number consistent.
- Add a phosphodiesterase inhibitor such as IBMX so that cAMP builds up.
- For Gi-coupled receptors, first raise cAMP with forskolin, then measure how much the peptide lowers it.
- Include a reference agonist on every plate and a no-peptide control.
- Use a wide, evenly spaced dilution series and fit with a four-parameter curve, as described in the dose-response guide.
Why EC50 values move
A compound’s EC50 is not a fixed constant. With many receptors on the cell surface, a small fraction needs to be occupied to get a full response, so apparent potency looks high. In cells with few receptors, the same compound may look weaker or only partially active. Incubation time, cell density and the presence of serum proteins that bind peptides can all shift the number. That is why comparisons are only meaningful on the same plate.
Beyond cAMP
cAMP is one pathway among several. Receptors can also recruit arrestin proteins or release calcium, and a compound may favor one route over another, as explained in our biased agonism post. A complete picture usually pairs cAMP with binding data and at least one other readout.
The bottom line
A well-run cAMP assay is a reliable way to compare how strongly peptides switch on a receptor. Good controls make the data believable. For more research methods, browse the Research Library.
Related reading
- Glucagon and the discovery of cAMP
- Biased agonism
- Radioligand binding assays
- Browse the full Research Library
Explore Lucid Aminos
- Shop all research compounds
- Read the lab reports (COA)
- Monthly Research Panel
- Frequently asked questions
- Partner program
- About Lucid Aminos
- Contact us
For laboratory research use only. Not for human or veterinary use, and not intended to diagnose, treat, cure or prevent any condition. This article is educational and is not medical advice.